comparemela.com

Page 12 - Cti Biopharma Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference

/PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen Annual Healthcare Conference.

Biopharma corpCowen annual healthcare conferenceAnnual healthcare conferencePharma investor contactsCti biopharma corpHealth care amp hospitalsComputer amp electronicsMedical pharmaceuticalsConference call announcements

CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference

/PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen Annual Healthcare Conference.

Biopharma corpCowen annual healthcare conferenceAnnual healthcare conferencePharma investor contactsCti biopharma corp

CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia

/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the.

New yorkUnited statesAdamr craigJohn mascarenhasIcahn school of medicine at mount sinaiTisch cancer instituteSecurities exchangeDrug administrationBiopharma corpAssociate professorMedical oncologyIcahn schoolMount sinaiChief executive officerJanus associated kinaseAdverse cardiac events

CTI BioPharma Announces FDA Accelerated Approval of VONJO™ (pacritinib) for the Treatment of Adult Patients with Myelofibrosis and Thrombocytopenia

/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. Food and Drug Administration (FDA) has approved VONJO (pacritinib) for the.

New yorkUnited statesAdamr craigJohn mascarenhasIcahn school of medicine at mount sinaiTisch cancer instituteSecurities exchangeDrug administrationBiopharma corpAssociate professorMedical oncologyIcahn schoolMount sinaiChief executive officerJanus associated kinaseAdverse cardiac events

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors.

United statesCompensation committeeBiopharma corpIncentive planNasdaq listing ruleGrant datePharma investorCti biopharma corp

vimarsana © 2020. All Rights Reserved.